3384 related articles for article (PubMed ID: 7399746)
21. Natural cytotoxicity of human blood lymphocytes and monocytes and their cytotoxic factors: effect of interferon on target cell susceptibility.
Uchida A; Vánky F; Klein E
J Natl Cancer Inst; 1985 Nov; 75(5):849-57. PubMed ID: 2414505
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-4 augments the cytotoxic capacity of lymphocytes and monocytes in antibody-dependent cellular cytotoxicity.
Wersäll P; Masucci G; Mellstedt H
Cancer Immunol Immunother; 1991; 33(1):45-9. PubMed ID: 2021957
[TBL] [Abstract][Full Text] [Related]
23. Human monocyte antibody-dependent cell-mediated cytotoxicity to tumor cells.
Shaw GM; Levy PC; LoBuglio AF
J Clin Invest; 1978 Dec; 62(6):1172-80. PubMed ID: 748372
[TBL] [Abstract][Full Text] [Related]
24. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
25. In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis.
Vierling JM; Nelson DL; Strober W; Bundy DM; Jones EA
J Clin Invest; 1977 Nov; 60(5):1116-28. PubMed ID: 332716
[TBL] [Abstract][Full Text] [Related]
26. The cytotoxic effector cells in preparations of adherent mononuclear cells from human peripheral blood.
Freundlich B; Trinchieri G; Perussia B; Zurier RB
J Immunol; 1984 Mar; 132(3):1255-60. PubMed ID: 6693767
[TBL] [Abstract][Full Text] [Related]
27. Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D.
Uchida A; Klein E
Int J Cancer; 1985 May; 35(5):691-9. PubMed ID: 3997288
[TBL] [Abstract][Full Text] [Related]
28. Role of interleukin 1 in promoting human monocyte-mediated tumor cytotoxicity.
Onozaki K; Matsushima K; Kleinerman ES; Saito T; Oppenheim JJ
J Immunol; 1985 Jul; 135(1):314-20. PubMed ID: 3873493
[TBL] [Abstract][Full Text] [Related]
29. Induction of cytotoxic activity in human lymphocytes against autologous and allogeneic melanoma cells in vitro by culture with interleukin 2.
Hersey P; Bindon C; Edwards A; Murray E; Phillips G; McCarthy WH
Int J Cancer; 1981 Dec; 28(6):695-703. PubMed ID: 6977498
[TBL] [Abstract][Full Text] [Related]
30. Recognition of autologous and allogeneic lymphocytes and tumor cells by human natural killer cells.
Benczur M; Sármay G; Laskay T; Gyódi E; Petrányi GG; Gergely J
Mol Immunol; 1982 Oct; 19(10):1331-40. PubMed ID: 6757725
[TBL] [Abstract][Full Text] [Related]
31. The role of monocytes in human lymphocyte activation by mitogens.
de Vries JE; Caviles AP; Bont WS; Mendelsohn J
J Immunol; 1979 Mar; 122(3):1099-107. PubMed ID: 448072
[TBL] [Abstract][Full Text] [Related]
32. Cyclosporin A enhances susceptibility of multi-drug resistant human cancer cells to anti-P-glycoprotein antibody-dependent cytotoxicity of monocytes, but not of lymphocytes.
Yano S; Sone S; Nishioka Y; Naito M; Tsuruo T; Ogura T
Jpn J Cancer Res; 1994 Feb; 85(2):194-203. PubMed ID: 7511575
[TBL] [Abstract][Full Text] [Related]
33. Spontaneous and antibody-dependent cellular cytotoxicity in melanoma patients and healthy control presons.
Peter HH; Knoop F; Kalden JR
Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(3):263-81. PubMed ID: 134545
[TBL] [Abstract][Full Text] [Related]
34. Induction of human monocyte-mediated tumor cell killing by a plant lectin, wheat germ agglutinin.
Ogawara M; Utsugi T; Yamazaki M; Sone S
Jpn J Cancer Res; 1985 Nov; 76(11):1107-14. PubMed ID: 2418002
[TBL] [Abstract][Full Text] [Related]
35. Separation of human lymphocytes and monocytes by velocity sedimentation at unit gravity.
Bont WS; De Vries JE; Geel M; Van Dongen A; Loos HA
J Immunol Methods; 1979; 29(1):1-16. PubMed ID: 489987
[TBL] [Abstract][Full Text] [Related]
36. Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies.
Ortaldo JR; Woodhouse C; Morgan AC; Herberman RB; Cheresh DA; Reisfeld R
J Immunol; 1987 May; 138(10):3566-72. PubMed ID: 2437198
[TBL] [Abstract][Full Text] [Related]
37. Human antibody-dependent cellular cytotoxicity. Isolation and identification of a subpopulation of peripheral blood lymphocytes which kill antibody-coated autologous target cells.
Brier AM; Chess L; Schlossman SF
J Clin Invest; 1975 Dec; 56(6):1580-6. PubMed ID: 53242
[TBL] [Abstract][Full Text] [Related]
38. In vitro cytotoxicity and transplantation protection by autologous natural and activated killer cells against an in vitro transformed tumorigenic fibroblast line. A case study.
Wilhelm SA; Mukherji B
J Clin Invest; 1985 Apr; 75(4):1162-8. PubMed ID: 3988936
[TBL] [Abstract][Full Text] [Related]
39. Monocyte-mediated augmentation of human natural killer cell activity: conditions, monocyte and effector cell characteristics.
Bloom ET; Babbitt JT; Kawakami K
J Immunol; 1986 Jul; 137(1):172-8. PubMed ID: 3711665
[TBL] [Abstract][Full Text] [Related]
40. Effector cells in natural cytotoxicity against human bladder cancer cell lines.
Bloom ET; Dunsworth-Browne M; Durkos-Smith D
Urol Res; 1981; 9(5):219-25. PubMed ID: 7303345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
